Navigation Links
New Plastic Blood Culture Bottles Increase Lab Convenience While Maintaining High-Quality Standards
Date:7/17/2012

BALTIMORE, July 17, 2012 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), today announced that it obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for BD BACTEC™ Plus Aerobic/F blood culture bottles in plastic, previously only available in glass.  Obtaining 510(k) clearance allows for increased convenience for customers without compromising the performance and quality of the system. 

"BD is pleased to offer our customers the convenience of plastic, while continuing to deliver outstanding performance and rapid time-to-detection that drive better sepsis and healthcare-associated infection diagnostics," said Tom Polen, President, BD Diagnostics – Diagnostic Systems.  "FDA clearance of the BD BACTEC Plus Aerobic/F blood culture plastic bottles represents BD's commitment to meeting customer needs without compromising clinical performance."

BD BACTEC Plus Aerobic/F blood culture plastic bottles provide customers with leading organism recovery through antibiotic neutralization and clear gram stain readability. The bottles run on currently available BD BACTEC™ systems, offering customers proven laboratory efficiency with optimized workflow and data management. The BD BACTEC™ Blood Culture System is a fully-automated microbiology growth and detection system designed to detect microbial growth from blood specimens. Top-notch performance is preserved along with rapid time-to-detection, enabling better diagnostics and patient care.

For more information on BD Blood Culture Systems, please visit http://www.bd.com/ds/productCenter/BC.asp.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact:
Jamie Yacco
Public Relations
(201) 847-4796
Jamie_Yacco@bd.com 

 


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cell Therapeutics to Host Investor and Analyst Meeting to Discuss Targeted Agents in Myelofibrosis and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia on Sunday, June 3, 2012, in Chicago
2. Global Growth Factors (Blood And Tissue) Industry
3. Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment
4. Spot On Sciences Awarded $1 Million DARPA Grant to Develop a Blood Sample Collection Device
5. OICR funds Fluorinov Pharma Inc. to further develop its novel drug for the treatment of blood cancers
6. Glooko Launches the Glooko™ IR Adapter to Give ACCU-CHEK® Blood Glucose Meter Customers Access to the Glooko Logbook Solution
7. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
8. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
9. Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications
10. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
11. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:2/4/2016)... Feb. 4, 2016 Summary Breast cancer, ... and the most common cancer in women worldwide, accounting ... exceedingly prevalent. The number of women diagnosed with breast ... the number of deaths has declined due to earlier ... has been revolutionized in the past four decades, especially ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
Breaking Medicine Technology:
(Date:2/6/2016)... ... 06, 2016 , ... Research has shown that building shame ... frequency and level of relapse. , At the 2016 iaedp Symposium, ... explore the critical tasks of the recovery phase and beyond including relapse prevention ...
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior ... that the much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will ... , Each week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... once again host, Swirl, A Wine Tasting Event at the La Gorce Country ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Regular gym users ... themselves having to wait longer to access the treadmills. It’s a predictable trend. After ... to lose weight and get in shape by joining gyms, starting new walking or ...
Breaking Medicine News(10 mins):